Literature DB >> 11743663

Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.

Christiane W Yorioka1, Ricardo D Coletta, Fabio Alves, Inês N Nishimoto, Luis Paulo Kowalski, Edgard Graner.   

Abstract

The aim of the present study was to determine whether matrix metalloproteinase (MMP) activities are associated with the clinicopathological features of oral squamous cell carcinomas (OSCCs). Forty-four samples of primary OSCCs were microdissected, incubated in serum-free cell culture medium for 16 h, and the activity of secreted MMPs analyzed by gelatin zymography and densitometry. Two major enzymes with gelatinolytic activity were produced by all tumor samples and characterized as MMP-2 and -9 by their molecular weight, immunoprecipitation using monoclonal antibodies, and specific inhibition by 1,10-phenanthroline or EDTA. Patients with tumors showing elevated activity of MMP-2 and -9 had shorter disease-free survival after treatment than patients with tumors exhibiting low MMP activities. These results suggest that the zymographic measurement of the MMP-2 and -9 activities in OSCC specimens may be useful to predict the disease-free survival period of patients affected by these tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11743663

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  18 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.

Authors:  Sabrina Daniela Silva; Moulay A Alaoui-Jamali; Michael Hier; Fernando Augusto Soares; Edgard Graner; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2013-12-15       Impact factor: 5.150

3.  The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.

Authors:  Ana Carolina Cuzzuol Fracalossi; Sandra Regina Miranda; Celina Tijuko Fujiyama Oshima; Marcello Franco; Daniel Araki Ribeiro
Journal:  J Mol Histol       Date:  2010-03-06       Impact factor: 2.611

Review 4.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

5.  The expression of metaloproteinases-2 and -9 is different according to the patterns of growth and invasion in squamous cell carcinoma of the penis.

Authors:  Fernando A Soares; Isabela Werneck da Cunha; Gustavo Cardoso Guimarães; Sueli Nonogaki; Rodrigo Sousa Madeira Campos; Ademar Lopes
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

6.  Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.

Authors:  De-Tao Tao; Zhen-Lin Gao; Jing-Ping Zhou; Lian-Ping He; Liu-Xia Shi; Yuan Fang; Wen-Jing Liu; Chao Deng
Journal:  Int J Clin Exp Med       Date:  2014-06-15

7.  Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.

Authors:  Hubert Vermeersch; Kris Mervillie; Christophe Lahorte; David Loose; Rudi Andre Dierck; Neil Steinmetz; Claude Cuvelier; Guido Slegers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

8.  Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

Authors:  G Tsiropoulos; T Papadas; Ie Triantaphyllidou; S Naxakis; K Markou; S Triaridis; I Vital; P Goumas; Dh Vynios
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

9.  Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

Authors:  N El Houda Agueznay; C Badoual; S Hans; A Gey; B Vingert; S Peyrard; F Quintin-Colonna; P Ravel; P Bruneval; S Roncelin; B Lelongt; J Bertoglio; W H Fridman; D Brasnu; E Tartour
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

Review 10.  Matrix metalloproteases in head and neck cancer.

Authors:  Eben L Rosenthal; Lynn M Matrisian
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.